ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

2023 COPD Guidelines Update

Antonio Anzueto

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

MUSC Cardiology

R. Mentz

COPD Exacerbations: if Not, What Else?

Temple Lung Center

J. Bon

Updates in Pulmonary Function Testing

National Jewish Health

M. Mohning

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

AHA 2022 Conference Coverage

R. Mentz

Bronchiectasis: What's New and What's Next?

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

S. Devarajan

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

Michelle Kittleson

COPD Classification and Practical Management Strategies

PulmPEEPs

D. Furfaro, K. Montemayor, R. A Wise, W. Labaki

Management of Heart Failure

Obafemi Awolowo University

O. A. Akinyele

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

Alpha One - Antitrypsin Deficiency: More Common Than You Think

Kyle Hogarth

Hot Topics in Heart Failure ACC.22

ACC 2022 Conference Coverage

N. Ibrahim

Weight Loss as Treatment for HFpEF: An Update on Drugs and Procedures

MUSC Cardiology

S. Litwin

CHEST Insights 2024: Determining the Impact of COVID-19 Infection on…

CHEST Annual Meeting Insights

A. Arumairaj

Updates in Chronic Obstructive Pulmonary Disease

Duke Health

Z. Hager

GOLD 2023 Update: Implications for Clinical Practice

Jill Ohar

Heart Failure Case Presentations

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

B. Greenberg, G. Fonarow, N. Wettersten, M. Rosa Costanzo

ACC 2024 Insights: Stop the Meds! Treat the Comorbidities for Optima…

ACC 2024 Insights

K. Williams